1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Immune Complex Diseases: new trials by email Literature Review of Immune Complex Diseases trials Research Report on Immune Complex Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Ravulizumab in Pediatric Participants With Primary IgAN Ravulizumab - IgAN, IgAVN | Phase 3 | Recruiting | Alexion Pharmaceuticals, Inc. | 36 | 2025-06-14 | 2026-07-30 |
Glomerulonephritis, IGA (1) · IgA Vasculitis (1) · Proteinuria (1)
Autoimmune Diseases (1) · Blood Coagulation Disorders (1) · Cardiovascular Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glomerulonephritis (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhage (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Hypersensitivity (1) · Immune System Diseases (1) · Kidney Diseases (1)
ravulizumab (1)
Alexion Pharmaceuticals, Inc. (1)
China (1) · Italy (1) · Japan (1) · South Korea (1) · Spain (1) · Taiwan (1) · United States (1)